Curaleaf Holdings (CURLF) Receivables - Other (2019 - 2026)
Curaleaf Holdings (CURLF) posted quarterly Receivables - Other of $5.1 million for Q4 2025, up 6.91% year-over-year from $4.8 million in Q4 2024, and up 6.91% quarter-over-quarter from $4.8 million in Q4 2024.
Curaleaf Holdings (CURLF) Receivables - Other (2019 - 2026) Analysis & Trends
Curaleaf Holdings' Receivables - Other history runs 7 years deep, the most recent figure standing at $5.1 million for Q4 2025.
- In Q4 2025, Receivables - Other rose 6.91% year-over-year to $5.1 million; the TTM figure through Dec 2025 stood at $5.1 million (up 6.91% YoY), while the FY2025 annual figure was $5.1 million, up 6.91% from the prior year.
- Receivables - Other for Q4 2025 stood at $5.1 million, up from $4.8 million in the prior quarter.
- The five-year high for Receivables - Other was $5.8 million in Q4 2021, with the low at -$67.5 million in Q3 2022.
- The 5-year median for Receivables - Other is $3.6 million (2023), against an average of -$13.9 million.
- The sharpest annual moves came in 2021 and 2023: Receivables - Other jumped 136.62% in 2021, then tumbled 50.42% in 2023.
- Curaleaf Holdings' Receivables - Other stood at $5.8 million in 2021, then dropped by 17.13% to $4.8 million in 2022, then sank by 50.42% to $2.4 million in 2023, then jumped by 100.21% to $4.8 million in 2024, then advanced by 6.91% to $5.1 million in 2025.
- Business Quant data shows CURLF's Receivables - Other at $5.1 million in Q4 2025, $4.8 million in Q4 2024, and $2.4 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Curaleaf Holdings | 2.48 Bn | 2.38 Bn | 169.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.28 Mn |
| Jun 30, 2026 | 6.28 Mn |
| Dec 31, 2025 | 5.09 Mn |
| Dec 31, 2025 | 5.09 Mn |
| Dec 31, 2024 | 4.76 Mn |
| Dec 31, 2024 | 4.76 Mn |
| Dec 31, 2023 | 2.38 Mn |
| Dec 31, 2023 | 2.38 Mn |
| Sep 30, 2023 | -32.45 Mn |
| Sep 30, 2023 | -32.45 Mn |
| Dec 31, 2022 | 4.80 Mn |
| Dec 31, 2022 | 4.80 Mn |
| Sep 30, 2022 | -67.52 Mn |
| Sep 30, 2022 | -67.52 Mn |
| Dec 31, 2021 | 5.79 Mn |
| Dec 31, 2021 | 5.79 Mn |
| Mar 31, 2021 | -33.75 Mn |
| Mar 31, 2021 | -33.75 Mn |
| Dec 31, 2020 | 2.45 Mn |
| Dec 31, 2020 | 2.45 Mn |